The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 10, 2024

Filed:

Apr. 23, 2018
Applicant:

Medtronic Ireland Manufacturing Unlimited Company, Dublin, IE;

Inventors:

Venmathi Gunasekaran, Santa Rosa, CA (US);

Douglas Hettrick, Andover, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/107 (2006.01); A61B 5/00 (2006.01); A61B 5/02 (2006.01); A61B 5/0535 (2021.01); A61B 5/0538 (2021.01); A61B 18/14 (2006.01); A61B 18/00 (2006.01); A61B 90/00 (2016.01);
U.S. Cl.
CPC ...
A61B 5/0538 (2013.01); A61B 5/02007 (2013.01); A61B 5/0535 (2013.01); A61B 5/1076 (2013.01); A61B 5/4035 (2013.01); A61B 5/4848 (2013.01); A61B 5/6857 (2013.01); A61B 18/1492 (2013.01); A61B 5/6853 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00511 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00702 (2013.01); A61B 2018/00761 (2013.01); A61B 2018/00875 (2013.01); A61B 2018/1435 (2013.01); A61B 2090/061 (2016.02); A61B 2505/05 (2013.01); A61B 2562/0209 (2013.01);
Abstract

Systems and methods for performing, assessing, and adjusting neuromodulation therapy are disclosed herein. One method for assessing the likely efficacy of neuromodulation therapy includes positioning a neuromodulation catheter at a target site within a renal blood vessel of a human patient and obtaining a measurement related to a diameter of the renal blood vessel via the neuromodulation catheter. The method can further include determining a diameter of the renal blood vessel at or near the target site based on the measurement. In some embodiments, (i) one or more parameters of neuromodulation energy to be delivered to the renal blood vessel can be adjusted based on the determined diameter and/or (ii) the neuromodulation catheter may be repositioned within the renal blood vessel.


Find Patent Forward Citations

Loading…